Lumiera Health Inc
XTSX:NHP

Watchlist Manager
Lumiera Health Inc Logo
Lumiera Health Inc
XTSX:NHP
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: CA$849.9k

Lumiera Health Inc
Investor Relations

Lumiera Health, Inc. engages in the commercialization and development of evidence-based botanical products for the healthcare and bio-agriculture. The company is headquartered in Montreal, Quebec. The company went IPO on 2013-11-14. The firm is focused on selling natural products as well as the development and commercialization of botanical-based products for human health care. The firm also operates as product development, marketing and sales business of natural products. The Company’s products and brands include Holizen, Awaye pain relief cream and Bazzzics. The firm is also providing solutions for chronic pain and inflammation. The company is also helping people to improve health by delivering products. The Company’s subsidiary is Holizen Laboratory Inc.

Show more
Loading
NHP
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Mario Paradis
Financial Consultant
No Bio Available
Mr. Carlos Ponce
CEO & Director
No Bio Available
Mr. Simon Castonguay
Interim CFO & Director
No Bio Available

Contacts

Address
QUEBEC
MONTREAL
1000 Sherbrooke St W Suite 2700
Contacts
+18667222442.0
www.lumiera.ca
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett